Beacon Financial Group Amgen Inc Transaction History

Beacon Financial Group

$913 Million
Q3 2024

A detailed history of Beacon Financial Group transactions in Amgen Inc stock. As of the latest transaction made, Beacon Financial Group holds 11,600 shares of AMGN stock, worth $3.06 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

11,600

Previous 11,928 2.75%

Holding current value

$3.06 Million

Previous $3.73 Million 0.3%

% of portfolio

0.41%

Previous 0.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $101,476 - $110,660	-328 Reduced 2.75%	11,600 $3.74 Million
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $102,735 - $124,850	-391 Reduced 3.17%	11,928 $3.73 Million
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $643,674 - $776,996	-2,394 Reduced 16.27%	12,319 $3.5 Million
Q4 2023 Feb 23, 2024	SELL	$255.7 - $288.46 $89,750 - $101,249	-351 Reduced 2.33%	14,713 $4.24 Million
Q3 2023 Oct 16, 2023	SELL	$218.65 - $271.46 $60,128 - $74,651	-275 Reduced 1.79%	15,064 $3.86 Million
Q2 2023 Jul 20, 2023	SELL	$214.27 - $253.37 $130,276 - $154,048	-608 Reduced 3.81%	15,339 $3.39 Million
Q1 2023 Apr 14, 2023	BUY	$225.79 - $275.2 $463,772 - $565,260	2,054 Added 14.78%	15,947 $4 Million
Q4 2022 Jan 19, 2023	SELL	$229.03 - $291.01 $8,932 - $11,349	-39 Reduced 0.28%	13,893 $3.61 Million
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $94,273 - $106,323	420 Added 3.11%	13,932 $3.18 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $11,996 - $13,350	-52 Reduced 0.38%	13,512 $3.3 Million
Q1 2022 Apr 08, 2022	SELL	$219.27 - $242.57 $12,717 - $14,069	-58 Reduced 0.43%	13,564 $3.3 Million
Q4 2021 Jan 07, 2022	SELL	$198.88 - $227.6 $3.09 Million - $3.54 Million	-15,535 Reduced 53.28%	13,622 $3.09 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $98,705 - $115,645	465 Added 1.62%	29,157 $4.83 Million
Q2 2021 Jul 26, 2021	SELL	$233.58 - $259.14 $56,526 - $62,711	-242 Reduced 0.84%	28,692 $5.11 Million
Q1 2021 Aug 16, 2021	BUY	$221.91 - $258.6 $3.37 Million - $3.93 Million	15,206 Added 110.77%	28,934 $4.94 Million
Q4 2020 Jan 15, 2021	SELL	$216.38 - $257.67 $2,163 - $2,576	-10 Reduced 0.07%	13,728 $3.32 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $55,846 - $62,106	-238 Reduced 1.7%	13,738 $3.49 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $1.06 Million - $1.3 Million	-5,373 Reduced 27.77%	13,976 $3.24 Million
Q1 2020 Jun 29, 2020	SELL	$182.24 - $241.7 $43,919 - $58,249	-241 Reduced 1.23%	19,349 $4.03 Million
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $29,327 - $37,696	155 Added 0.8%	19,590 $4.72 Million
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $1.1 Million - $1.32 Million	-6,340 Reduced 24.6%	19,435 $3.79 Million
Q2 2019 Jul 15, 2019	SELL	$166.7 - $195.41 $3,334 - $3,908	-20 Reduced 0.08%	25,775 $4.75 Million
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $859,313 - $968,633	-4,751 Reduced 15.55%	25,795 $4.9 Million
Q4 2018 Jan 16, 2019	SELL	$178.4 - $208.25 $22,478 - $26,239	-126 Reduced 0.41%	30,546 $5.83 Million
Q3 2018 Oct 10, 2018	SELL	$185.29 - $208.89 $2.01 Million - $2.27 Million	-10,861 Reduced 26.15%	30,672 $6.36 Million
Q2 2018 Jul 11, 2018	SELL	$166.05 - $186.51 $92,323 - $103,699	-556 Reduced 1.32%	41,533 $7.67 Million
Q1 2018 Apr 06, 2018	SELL	$169.43 - $198.0 $468,304 - $547,272	-2,764 Reduced 6.16%	42,089 $7.18 Million
Q4 2017 Jan 03, 2018	SELL	$168.79 - $188.59 $286,943 - $320,603	-1,700 Reduced 3.65%	44,853 $7.8 Million
Q3 2017 Oct 03, 2017	BUY	$167.29 - $191.0 $7.79 Million - $8.89 Million	46,553	46,553 $8.68 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Financial Group with notifications on news.

Account

Beacon Financial Group Amgen Inc Transaction History